Produced by Araxis Merge on 2/19/2018 2:07:53 PM Eastern Standard Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
| # | Location | File | Last Modified |
|---|---|---|---|
| 1 | OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package.zip\OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package\OneVA_Pharmacy_CAS_MPDU_Build-2_Test_Cases | CAS_MPDU_TC_031_ Allow leading zeros in prescription quantity.docx | Mon Jan 8 17:06:42 2018 UTC |
| 2 | OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package.zip\OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package\OneVA_Pharmacy_CAS_MPDU_Build-2_Test_Cases | CAS_MPDU_TC_031_ Allow leading zeros in prescription quantity.docx | Mon Feb 19 17:56:38 2018 UTC |
| Description | Between Files 1 and 2 |
|
|---|---|---|
| Text Blocks | Lines | |
| Unchanged | 7 | 1090 |
| Changed | 6 | 12 |
| Inserted | 0 | 0 |
| Removed | 0 | 0 |
| Whitespace | |
|---|---|
| Character case | Differences in character case are significant |
| Line endings | Differences in line endings (CR and LF characters) are ignored |
| CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
| 1 | Department of Vetera ns Affairs | |
| 2 | ||
| 3 | Clinical A ncillary S ervices (C AS) | |
| 4 | ||
| 5 | ||
| 6 | Build 2 | |
| 7 | Sprint-3 | |
| 8 | Test Case CAS_TC_031 | |
| 9 | ||
| 10 | CLIN# 0004 AE | |
| 11 | December 2 017 | |
| 12 | Version 1. 0 | |
| 13 | Revision H istory | |
| 14 | Date | |
| 15 | Version | |
| 16 | Descriptio n | |
| 17 | Author | |
| 18 | 08/04/2017 | |
| 19 | 1.0 | |
| 20 | Initial dr aft | |
| 21 | Joseph A. McGovern | |
| 22 | Template R evision Hi story | |
| 23 | Date | |
| 24 | Version | |
| 25 | Descriptio n | |
| 26 | Author | |
| 27 | 08/04/2017 | |
| 28 | 1.0 | |
| 29 | Constructe d for CAS based on h istorical Test Case format use d on prior VA Projec ts | |
| 30 | Joseph A. McGovern | |
| 31 | ||
| 32 | ||
| 33 | Table of C ontents | |
| 34 | 1Product D escription 1 | |
| 35 | 1.1Purpose 1 | |
| 36 | 1.2Scope1 | |
| 37 | 2Test Case | |
| 38 | Appendix A .Acronyms & Abbrevia tions9 | |
| 39 | ||
| 40 | ||
| 41 | Product De scription | |
| 42 | OneVA Phar macy Clin ical Ancil lary Servi ces (CAS) project | |
| 43 | Purpose | |
| 44 | The purpos e of this document i s to devel op test ca se scenari os to iden tify, clar ify, and o rganize CA S applicat ion requir ements. Th e test cas e is made up of a se t of possi ble sequen ces of int eractions between sy stems and users in t he CHYSHR and DAYTSH R environm ents to va lidate and verify th at OneVA P harmacy so ftware Out patient Ph armacy Pre scription Processing will allo w leading zero in fr actional q uantity pr escription s so that I can redu ce confusi on and ens ure the ac curate qua ntity is d ispensed o n outpatie nt medicat ions. | |
| 45 | The CHYSHR environme nt is the Host site. The DAYT SHR enviro nment is t he dispens ing site ( remote). | |
| 46 | The test c ase should contain a ll system activities that have significa nce to the Pharmacis t users. | |
| 47 | Scope | |
| 48 | OneVA Phar macy softw are Outpat ient Pharm acy Prescr iption Pro cessing wi ll allow l eading zer o in fract ional quan tity presc riptions s o that I c an reduce confusion and ensure the accur ate quanti ty is disp ensed on o utpatient medication s. | |
| 49 | Test Case | |
| 50 | CAS Test C ases and s upporting test scrip ts will be recorded managed in VA Enterp rise Jazz Rational Q uality Man ager Tool PBM(QM). Stakeholde rs can als o provide inputs abo ut the cur rent set o f test cas es as well as sugges t some mor e missing test cases . | |
| 51 | This test case will: | |
| 52 | Capture an d communic ate functi onal requi rements fo r software developme nt; and | |
| 53 | Provide a set of tes t inputs, execution conditions , and expe cted resul ts develop ed for a p articular objective, such as t o exercise a particu lar progra m path or to verify compliance with a sp ecific req uirement o r defect r emediation . | |
| 54 | Allow lead ing zero i n fraction al quantit y prescrip tions so t hat I can reduce con fusion and ensure th e accurate quantity is dispens ed on outp atient med ications | |
| 55 | ||
| 56 | Field | |
| 57 | Descriptio n | |
| 58 | Test Case ID: | |
| 59 | CAS_MPDU_T C_031_ All ow leading zeros in prescripti on quantit y | |
| 60 | RTC ID: | |
| 61 | 610135 | |
| 62 | RM ID: | |
| 63 | 167728 | |
| 64 | QM ID: | |
| 65 | 945427 | |
| 66 | Tester: | |
| 67 | Samatha Gi rla | |
| 68 | Environmen t: | |
| 69 | DAYTSHR | |
| 70 | Build : | |
| 71 | PSD_3_83_2 0171218A.K ID,PSO_7_5 05_2017121 9A.KID,PSS _1_219_201 71204B.KID ,XU_8_689_ 20171124B. KID | |
| 72 | ||
| 73 | Use Case N ame: | |
| 74 | Selectivel y Process Rxs for Su pply Items - NSR #20 160414 | |
| 75 | Scenario: | |
| 76 | As a pharm acist, I n eed the sy stem to al low leadin g zeros in fractiona l quantity prescript ions so th at I can r educe conf usion and ensure the accurate quantity i s dispense d on outpa tient medi cations. | |
| 77 | Actors: | |
| 78 | Pharmacist | |
| 79 | Pre-Condit ion: | |
| 80 | The Pharma cist must have an ac tive VistA account w ith access to the On eVA Pharma cy Program . | |
| 81 | ||
| 82 | ||
| 83 | Post-Condi tion | |
| 84 | Upon entry of valid access and verify co des on Out Patient Ph armacy Pre scription Processing system wi ll allow l eading zer o in fract ional quan tity presc riptions t o ensure t he accurat e quantity is dispen sed on out patient me dications. | |
| 85 | ||
| 86 | ||
| 87 | Steps | |
| 88 | ||
| 89 | Pass | |
| 90 | Fail | |
| 91 | ||
| 92 | Actions | |
| 93 | Pass | |
| 94 | ||
| 95 | ||
| 96 | Log into t he ‘HOST’ system DA YTSHR . | |
| 97 | ||
| 98 | ||
| 99 | ||
| 100 | Expected R esults | |
| 101 | ||
| 102 | ||
| 103 | ||
| 104 | User will be taken t o the acce ss/verify code promp ts. | |
| 105 | ||
| 106 | ||
| 107 | ||
| 108 | Actions | |
| 109 | Pass | |
| 110 | ||
| 111 | ||
| 112 | Enter your access/ve rify code( s). | |
| 113 | ||
| 114 | ||
| 115 | ||
| 116 | Expected R esults | |
| 117 | ||
| 118 | ||
| 119 | ||
| 120 | User it ta ken to the default m enu promp t. | |
| 121 | ||
| 122 | ||
| 123 | ||
| 124 | Actions | |
| 125 | Pass | |
| 126 | ||
| 127 | ||
| 128 | When promp ted ‘ISPA0 4:DAYTSHR> ’ D ^XUP | |
| 129 | :”, press <return> | |
| 130 | ||
| 131 | ||
| 132 | ||
| 133 | Expected R esults | |
| 134 | ||
| 135 | ||
| 136 | ||
| 137 | User is ta ken to the next prom pt. | |
| 138 | ||
| 139 | ||
| 140 | ||
| 141 | Actions | |
| 142 | Pass | |
| 143 | ||
| 144 | ||
| 145 | Select OPT ION NAME: PSO LM BAC KDOOR ORDE RS | |
| 146 | ||
| 147 | ||
| 148 | ||
| 149 | Expected R esults | |
| 150 | ||
| 151 | ||
| 152 | ||
| 153 | System wil l ask to e nter divis ion | |
| 154 | ||
| 155 | ||
| 156 | ||
| 157 | Actions | |
| 158 | Pass | |
| 159 | ||
| 160 | ||
| 161 | Division:9 84 AND pre ss <Return > | |
| 162 | ||
| 163 | ||
| 164 | ||
| 165 | Expected R esults | |
| 166 | ||
| 167 | ||
| 168 | ||
| 169 | Select LAB EL PRINTER : HOME// SECURE Right Mar gin: 80// | |
| 170 | ||
| 171 | ||
| 172 | ||
| 173 | Actions | |
| 174 | Pass | |
| 175 | ||
| 176 | ||
| 177 | Press <Ret urn> until see the o ption Sele ct PATIENT NAME: | |
| 178 | ||
| 179 | ||
| 180 | ||
| 181 | Expected R esults | |
| 182 | ||
| 183 | ||
| 184 | ||
| 185 | Select PAT IENT NAME: | |
| 186 | ||
| 187 | ||
| 188 | 7 | |
| 189 | Actions | |
| 190 | Pass | |
| 191 | ||
| 192 | ||
| 193 | Enter pati ent name w ho meets t he pre con ditions AN D PRESS <R eturn>. He re for tes ting selec ted ‘GREEN E,MAGGIE S R’ | |
| 194 | ||
| 195 | ||
| 196 | ||
| 197 | Expected R esults | |
| 198 | ||
| 199 | ||
| 200 | ||
| 201 | GREEN E,MAGGIE S R (420-33- 9009) | |
| 202 | ||
| 203 | Remote dat a not avai lable - On ly local o rder check s processe d. | |
| 204 | ||
| 205 | Eligibilit y: SERVICE CONNECTED 50% to 10 0% SC% : 100 | |
| 206 | RX PATIENT STATUS: S C// | |
| 207 | ||
| 208 | ||
| 209 | 8 | |
| 210 | Actions | |
| 211 | Pass | |
| 212 | ||
| 213 | ||
| 214 | Press<Retu rn> until you see th e Medicati on Profile | |
| 215 | ||
| 216 | ||
| 217 | ||
| 218 | Expected R esults | |
| 219 | ||
| 220 | ||
| 221 | ||
| 222 | Medication Profile Jan 04, 20 18@14:49:0 2 Page: 1 of 3 | |
| 223 | GREENE,MAG GIE SR | |
| 224 | PID: 420 -33-9009 Ht(cm): _ ______ (__ ____) | |
| 225 | DOB: PII Wt(kg): __ _____ (___ ___) | |
| 226 | SEX: FEM ALE | |
| 227 | CrCL: <No t Found> B SA (m2): _ ______ | |
| 228 | ISSUE LA ST REF DAY | |
| 229 | # RX # DRU G QTY ST DATE FI LL REM SUP | |
| 230 | ||
| 231 | ---------- ---------- ---------- -------ACT IVE------- ---------- ---------- ---------- | |
| 232 | 1 8001586 41 ABU PREN 5 A 12-05 12- 05 0 5 | |
| 233 | 2 2719146 BEN AZEPRIL HC L 20MG TAB 30 A> 06-19 11- 21 6 15 | |
| 234 | 3 2719179 BUP RENORPHINE 150MCG FI LM,BUCCAL 30 A 12-19 12- 19 0 30 | |
| 235 | 4 2719180 BUP RENORPHINE 2MG/NALOX ONE 0.5MG SL FILM A 12-19 12- 19 3 7 | |
| 236 | Qty: 7 | |
| 237 | 5 2719181 BUP RENORPHINE 2MG/NALOX ONE 0.5MG SL TAB A 12-19 12- 19 0 7 | |
| 238 | Qty: 7 | |
| 239 | 6 2719182 BUP RENORPHINE 8MG/NALOX ONE 2MG SL TAB 5 A 12-19 12- 19 0 5 | |
| 240 | 7 8001586 40 SUB OXONE BUPR ENORPHINE 30 A 12-05 12- 05 0 30 | |
| 241 | + Enter ?? f or more ac tions | |
| 242 | PU Patien t Record U pdate NO New Or der | |
| 243 | PI Patien t Informat ion SO Select Order | |
| 244 | Select Act ion: Next Screen// | |
| 245 | ||
| 246 | ||
| 247 | 9 | |
| 248 | Actions | |
| 249 | Pass | |
| 250 | ||
| 251 | ||
| 252 | Select any active or der and pr ess Return , here se lected ‘6’ | |
| 253 | ||
| 254 | ||
| 255 | ||
| 256 | Expected R esults | |
| 257 | ||
| 258 | ||
| 259 | ||
| 260 | OP Medicat ions (ACTI VE) Jan 04, 20 18@14:56:2 1 Page: 1 of 3 | |
| 261 | GREENE,MAG GIE SR | |
| 262 | PID: 420 -33-9009 Ht(cm): _ ______ (__ ____) | |
| 263 | DOB: PII Wt(kg): __ _____ (___ ___) | |
| 264 | SEX: FEM ALE | |
| 265 | CrCL: <No t Found> B SA (m2): _ ______ | |
| 266 | + | |
| 267 | SIG : DISSOLVE 1.25MG UN DER TONGUE EVERY MOR NING | |
| 268 | (5) Pati ent Status : SC | |
| 269 | (6) Issue Date : 12/19/17 (7) Fill Date: 12/19/17 | |
| 270 | Last Fill Date : 12/19/17 (Window) | |
| 271 | Last Re lease Date : (8) Lot #: | |
| 272 | Expires : 01/18/18 MFG: | |
| 273 | (9) D ays Supply : 5 (10) QTY (TAB): 5 | |
| 274 | (11) # of Refills : 0 Remaining: 0 | |
| 275 | (12) Provider : GIRLA,SA MATHA | |
| 276 | DEA# : DG456789 0 DETOX#: XT 4567899 | |
| 277 | + Digitally Signed Ord er | |
| 278 | DC Disco ntinue PR Partial RL Rel ease | |
| 279 | ED Edit RF (Refill) RN (Re new) | |
| 280 | ||
| 281 | ||
| 282 | 10 | |
| 283 | Actions | |
| 284 | Pass | |
| 285 | ||
| 286 | ||
| 287 | Select ‘ED ’ and pres s <Return> | |
| 288 | ||
| 289 | ||
| 290 | ||
| 291 | Expected R esults | |
| 292 | ||
| 293 | ||
| 294 | ||
| 295 | Select fie lds by num ber: (1-1 9): | |
| 296 | ||
| 297 | ||
| 298 | 11 | |
| 299 | Actions | |
| 300 | Pass | |
| 301 | ||
| 302 | ||
| 303 | Select ‘1 0’ and pre ss <Return > | |
| 304 | ||
| 305 | ||
| 306 | ||
| 307 | Expected R esults | |
| 308 | ||
| 309 | ||
| 310 | ||
| 311 | QTY ( TAB ) : 5// | |
| 312 | ||
| 313 | ||
| 314 | 12 | |
| 315 | Actions | |
| 316 | Pass | |
| 317 | ||
| 318 | ||
| 319 | Enter ‘.5’ and press <Return> | |
| 320 | ||
| 321 | ||
| 322 | ||
| 323 | Expected R esults | |
| 324 | ||
| 325 | ||
| 326 | ||
| 327 | Are You Su re You Wan t to Updat e Rx 27191 82? Yes// | |
| 328 | ||
| 329 | ||
| 330 | 14 | |
| 331 | Actions | |
| 332 | ||
| 333 | ||
| 334 | ||
| 335 | Press <Ret urn> | |
| 336 | ||
| 337 | ||
| 338 | ||
| 339 | Expected R esults | |
| 340 | ||
| 341 | ||
| 342 | ||
| 343 | Quantity f ield shoul d be displ ayed with 0.5 | |
| 344 | ||
| 345 | OP Medicat ions (ACTI VE) Jan 04, 20 18@15:01:0 2 Page: 1 of 3 | |
| 346 | GREENE,MAG GIE SR | |
| 347 | PID: 420 -33-9009 Ht(cm): _ ______ (__ ____) | |
| 348 | DOB: PII Wt(kg): __ _____ (___ ___) | |
| 349 | SEX: FEM ALE | |
| 350 | CrCL: <No t Found> B SA (m2): _ ______ | |
| 351 | + | |
| 352 | *Schedule : QAM | |
| 353 | (4)Pat In structions : | |
| 354 | SIG : DISSOLVE 1.25MG UN DER TONGUE EVERY MOR NING | |
| 355 | (5) Pati ent Status : SC | |
| 356 | (6) Issue Date : 12/19/17 (7) Fill Date: 12/19/17 | |
| 357 | Last Fill Date : 12/19/17 (Window) | |
| 358 | Last Re lease Date : (8) Lot #: | |
| 359 | Expires : 01/18/18 MFG: | |
| 360 | (9) D ays Supply : 5 (10) QTY (TAB): 0.5 | |
| 361 | (11) # of Refills : 0 Remaining: 0 | |
| 362 | (12) Provider : GIRLA,SA MATHA | |
| 363 | DEA# : DG456789 0 DETOX#: XT 4567899 | |
| 364 | + Digitally Signed Ord er | |
| 365 | DC Disco ntinue PR Partial RL Rel ease | |
| 366 | ED Edit RF (Refill) RN (Re new) | |
| 367 | Select Act ion: Next Screen// | |
| 368 | ||
| 369 | ||
| 370 | ||
| 371 | 13 | |
| 372 | Actions | |
| 373 | Pass | |
| 374 | ||
| 375 | ||
| 376 | Print the label and check for quantity | |
| 377 | ||
| 378 | ||
| 379 | ||
| 380 | Expected R esults | |
| 381 | ||
| 382 | ||
| 383 | ||
| 384 | Quality sh ould be up dated be u pdated as 0.5 | |
| 385 | ||
| 386 | ||
| 387 | Pending Or ders | |
| 388 | 15 | |
| 389 | Actions | |
| 390 | Pass | |
| 391 | ||
| 392 | ||
| 393 | Repeat the steps 3-8 | |
| 394 | ||
| 395 | ||
| 396 | ||
| 397 | Expected R esults | |
| 398 | ||
| 399 | ||
| 400 | ||
| 401 | Medication Profile Jan 04, 20 18@15:14:1 3 Page: 1 of 4 | |
| 402 | GREENE,MAG GIE SR | |
| 403 | PID: 420 -33-9009 Ht(cm): _ ______ (__ ____) | |
| 404 | DOB: PII Wt(kg): __ _____ (___ ___) | |
| 405 | SEX: FEM ALE | |
| 406 | CrCL: <No t Found> B SA (m2): _ ______ | |
| 407 | ISSUE LA ST REF DAY | |
| 408 | # RX # DRU G QTY ST DATE FI LL REM SUP | |
| 409 | ||
| 410 | ---------- ---------- ---------- -------ACT IVE------- ---------- ---------- ---------- | |
| 411 | 1 8001586 41 ABU PREN 5 A 12-05 12- 05 0 5 | |
| 412 | 2 2719146 BEN AZEPRIL HC L 20MG TAB 30 A> 06-19 11- 21 6 15 | |
| 413 | 3 2719179 BUP RENORPHINE 150MCG FI LM,BUCCAL 30 A 12-19 12- 19 0 30 | |
| 414 | 4 2719180 BUP RENORPHINE 2MG/NALOX ONE 0.5MG SL FILM A 12-19 12- 19 3 7 | |
| 415 | Qty: 7 | |
| 416 | 5 2719181 BUP RENORPHINE 2MG/NALOX ONE 0.5MG SL TAB A 12-19 12- 19 0 7 | |
| 417 | Qty: 7 | |
| 418 | 6 2719182 BUP RENORPHINE 8MG/NALOX ONE 2MG SL TAB A 12-19 12- 19 0 5 | |
| 419 | Q ty: 0.5 | |
| 420 | + Enter ?? f or more ac tions | |
| 421 | PU Patien t Record U pdate NO New Or der | |
| 422 | PI Patien t Informat ion SO Select Order | |
| 423 | Select Act ion: Next Screen// | |
| 424 | ||
| 425 | ||
| 426 | 16 | |
| 427 | Actions | |
| 428 | Pass | |
| 429 | ||
| 430 | ||
| 431 | Select pe nding orde r and pres s <Return> here sele cted ‘17’ | |
| 432 | ||
| 433 | ||
| 434 | ||
| 435 | Expected R esults | |
| 436 | ||
| 437 | ||
| 438 | ||
| 439 | ||
| 440 | ||
| 441 | ||
| 442 | Pending OP Orders (R OUTINE) Jan 04, 20 18@15:17:5 1 Page: 1 of 2 | |
| 443 | GREENE,MAG GIE SR | |
| 444 | PID: 420 -33-9009 Ht(cm): _ ______ (__ ____) | |
| 445 | DOB: PII Wt(kg): __ _____ (___ ___) | |
| 446 | ||
| 447 | *(1) Order able Item: LISINOPRI L TAB | |
| 448 | (2) CMOP Drug: LISINOPRI L 5MG TAB <DIN> | |
| 449 | Dru g Message: NO BID DO SING! | |
| 450 | (3) *Dosage: 5 (MG) | |
| 451 | Verb: TAKE | |
| 452 | Dispe nse Units: 1 | |
| 453 | Noun: TABLET | |
| 454 | *Route: MOUTH | |
| 455 | *Schedule: BID | |
| 456 | *Duration: 5D (DAYS) | |
| 457 | (4) Pat Instruct: TESTING | |
| 458 | Provider Comments: | |
| 459 | Ins tructions: | |
| 460 | SIG: TAKE ONE TABLET BY MOUTH TWIC E A DAY FO R 5 DAYS | |
| 461 | + Enter ?? f or more ac tions | |
| 462 | BY Bypass DC Discontinu e FL Flag /Unflag | |
| 463 | ED Edit FN Finish | |
| 464 | Select Ite m(s): Next Screen// | |
| 465 | ||
| 466 | ||
| 467 | ||
| 468 | 10 | |
| 469 | Actions | |
| 470 | Pass | |
| 471 | ||
| 472 | ||
| 473 | Select ‘ED ’ and pres s <Return> | |
| 474 | ||
| 475 | ||
| 476 | ||
| 477 | Expected R esults | |
| 478 | ||
| 479 | ||
| 480 | ||
| 481 | Select fie lds by num ber: (1-1 9): | |
| 482 | ||
| 483 | ||
| 484 | 11 | |
| 485 | Actions | |
| 486 | Pass | |
| 487 | ||
| 488 | ||
| 489 | Select ‘9 ’ and pres s <Return> | |
| 490 | ||
| 491 | ||
| 492 | ||
| 493 | Expected R esults | |
| 494 | ||
| 495 | ||
| 496 | ||
| 497 | QTY ( TAB ) : 30// | |
| 498 | ||
| 499 | ||
| 500 | 12 | |
| 501 | Actions | |
| 502 | Pass | |
| 503 | ||
| 504 | ||
| 505 | Enter ‘.5’ and press <Return> | |
| 506 | ||
| 507 | ||
| 508 | ||
| 509 | Expected R esults | |
| 510 | ||
| 511 | ||
| 512 | ||
| 513 | Pending OP Orders (R OUTINE) Jan 04, 20 18@15:21:5 3 Page: 1 of 2 | |
| 514 | GREENE,MAG GIE SR | |
| 515 | PID: 420 -33-9009 Ht(cm): _ ______ (__ ____) | |
| 516 | DOB: PII Wt(kg): __ _____ (___ ___) | |
| 517 | + | |
| 518 | (4) Pat Instruct: TESTING | |
| 519 | Provider Comments: | |
| 520 | Ins tructions: | |
| 521 | SIG: TAKE ONE TABLET BY MOUTH TWIC E A DAY FO R 5 DAYS | |
| 522 | (5) Patie nt Status: SC | |
| 523 | (6) I ssue Date: JUN 19,20 17 ( 7) Fill Da te: JAN 4, 2018 | |
| 524 | (8) Da ys Supply: 15 (9 ) QTY (T AB): 0.5 | |
| 525 | Pro vider orde red 6 refi lls | |
| 526 | (10) # o f Refills: 6 (11 ) Routin g: MAIL | |
| 527 | (12) Clinic: | |
| 528 | (13) Provider: EPRESCRIB ER,ERXAUTO MATED MR | |
| 529 | (14) Copies: 1 | |
| 530 | (15) Remarks: | |
| 531 | Entry B y: EPRESCR IBER,ERXAU TOMATED MR En try Date: 06/19/17 | |
| 532 | Enter ?? f or more ac tions | |
| 533 | AC Accept ED E dit DC Disco ntinue | |
| 534 | Select Ite m(s): Edit // | |
| 535 | ||
| 536 | ||
| 537 | Acronyms & Abbreviat ions | |
| 538 | Acronym | |
| 539 | Definition | |
| 540 | CAS | |
| 541 | Clinical A ncillary S ervices | |
| 542 | CHYSHR | |
| 543 | Test Envir onment fo r Host sit e | |
| 544 | CPRS | |
| 545 | Computeriz ed Patient Record Sy stem | |
| 546 | DAYTSHR | |
| 547 | Test Envir onment fo r the disp ensing sit e (remote) | |
| 548 | VHA | |
| 549 | Veteran’s Health Adm inistratio n | |
| 550 | VistA | |
| 551 | Veterans H ealth Info rmation Sy stems and Technology Architect ure |
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.